Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Uterine Neoplasms 1 Sleep Wake Disorders 1 Sleep Initiation and Maintenance Disorders 1 Pancreatic Neoplasms 1 Pain 1 Ovarian Neoplasms 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Multiple Myeloma 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Glioblastoma 1 Fatigue 1 Esophageal Neoplasms 1 Depression 1 Brain Neoplasms 1 Anxiety Disorders 1

Interventions

Temozolomide 163 Radiosurgery 129 Radiotherapy 107 Bevacizumab 98 Magnetic Resonance Spectroscopy 75 Carboplatin 48 Surgical Procedures, Operative 35 pembrolizumab 34 Radiation 34 Etoposide 34 Nivolumab 33 Irinotecan 33 Cyclophosphamide 33 Erlotinib Hydrochloride 31 Carmustine 28 Lomustine 26 Trastuzumab 25 Cisplatin 25 Ipilimumab 24 Filgrastim 23 Mental Status and Dementia Tests 21 Magnetic Resonance Imaging 21 Aminolevulinic Acid 21 Vincristine 20 Surveys and Questionnaires 19 Capecitabine 19 Topotecan 18 Specimen Handling 18 Pemetrexed 18 Radiotherapy, Intensity-Modulated 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × Acceptance and Commitment Therapy × CNS × Clear all

NCT04722237 2023-08-31

ACT NOW

Nottingham University Hospitals NHS Trust

Phase NA Unknown

Brain Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡